Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? | Neurology Neuroimmunology & Neuroinflammation
Neuromyelitis optica spectrum disorders | RCP Journals
Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
What You Need to Know About AQP4, MOG, and NMOSD
MOG ANTIBODY DISEASE: A RELATIVELY VAGUE CLINICAL PRESENTATION IN A PEDIATRIC PATIENT - SHM Abstracts | Society of Hospital Medicine
Neuromyelitis optica spectrum and myelin oligodendrocyte glycoprotein antibody‐related disseminated encephalomyelitis - Misu - 2019 - Clinical and Experimental Neuroimmunology - Wiley Online Library
Diagnostic implications of MOG/AQP4 antibodies in recurrent optic neuritis
Figure Model contrasting the potential role of antibodies to myelin oligodendrocyte glycoprotein (MOG) or aquaporin-4 (AQP4) in opticospinal inflammationMOG-specific. - ppt download
NMO-Specific Antibodies: Important Information to Know
New publication from IMSVISUAL members – OCT in MOG – IMSVISUAL
A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies
Quantitative brain lesion distribution may distinguish MOG-ab and AQP4-ab neuromyelitis optica spectrum disorders | SpringerLink
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? | Neurology Neuroimmunology & Neuroinflammation
Frontiers | Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
Myelin oligodendrocyte glycoprotein antibodies in neurological disease | Nature Reviews Neurology
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders | Journal of Neuroinflammation | Full Text
Vicente Martín on Twitter: "MOG in NMOSD Patients They have a different immunopathogenic mechanism in MOG-IgG–positive Neuromyelitis Optica Spectrum Disorders patients With some clinical, epidemiologic, and radiologic features distinct from those in
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype | Journal of Neuroinflammation | Full Text
A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
Recent developments in MOG-IgG associated neurological disorders - Harald Hegen, Markus Reindl, 2020
Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature - ScienceDirect
Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease | Journal of Neurology, Neurosurgery & Psychiatry
What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients | SpringerLink
Binding patterns and functional properties of human antibodies to AQP4 and MOG on murine optic nerve and retina - ScienceDirect
